Latest Video Updates

Upcoming Oncology Education Events

OncologyEducation Events Video Archives

Oncology Clinical News

FDA Expands Approval Of Adcetris For First-Line Treatment Of Stage III Or IV Classical Hodgkin Lymphoma In Combination With Chemotherapy

( Mar 20, 2018 - The U.S. Food and Drug Administration today approved Adcetris (brentuximab vedotin) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy.
Read full article.

T-VEC Immunotherapy Now Injected Into Liver Metastases

(Medscape Medical News) Mar 21, 2018 - The oncologic immunotherapy talimogene laherparepvec (T-VEC, Amgen Inc), already approved for the treatment of melanoma in the United States, is now being explored for its potential to eradicate advanced tumors in patients with primary and metastatic liver cancer.
Read full article.

Powered by OBR Oncology